On August 22nd, according to CoinDesk, the founder of VitaDAO, a decentralized autonomous organization that aims to fund longevity research projects, has launched a new protocol called BIO, which aims to enable the global community of patients, scientists and biotech developers to jointly provide financial support for the development and commercialization of new therapies. The protocol raises funds through decentralized autonomous organizations (DAOs) and uses the funds from token sales to support related biotech projects, thus enabling the sharing of intellectual property. BIO raised $6.20 million in a public sale during its initial coin generation (TGE) campaign, which included VCs such as ZeePrime and 1kx. Details of the second round of TGE will be announced soon.